Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.71 |
| ▸ | APP | P05067 | 1/20 | 0.71 |
| ▸ | GLB1 | P16278 | 1/20 | 0.71 |
| ▸ | CHAT | P28329 | 1/20 | 0.71 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.71 |
| ▸ | CTRC | Q99895 | 1/20 | 0.71 |
| ▸ | ALB | P02768 | 1/20 | 0.61 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1897261 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| SCHEMBL2868747 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| SCHEMBL23787656 | 0.87 | ALDH1A1 (0.77) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| SCHEMBL11922531 | 0.86 | SENP2 (0.79) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| SCHEMBL19154084 | 0.86 | SENP2 (0.79) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| SCHEMBL29382082 | 0.85 | THRB (0.74) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| Congo Red Free Acid SCHEMBL29395841 | 0.83 | APP (1.00) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| Congo Red Free Acid SCHEMBL29366109 | 0.83 | APP (1.00) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| Congo Red Free Acid SCHEMBL25635 | 0.83 | APP (1.00) | ALDH1A1CYP3A4THRBHPGDALOX15 | |
| Congo Red Free Acid SCHEMBL202229 | 0.83 | APP (1.00) | ALDH1A1CYP3A4THRBHPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114867351-B | 4' -Halogen-containing nucleotide and nucleoside therapeutic compositions and related uses | 埃默里大学 | 2024-04-23 | — | — | CN | claimed |
| US-11795340-B2 | Compositon sensitive to UV-C radiation and UV-C sterilization or disinfection dosimeter | TERRAGENE S.A. (AR) | 2023-10-24 | — | — | US | claimed |
| CN-114867351-A | 4' -halo-containing nucleotide and nucleoside therapeutic compositions and uses related thereto | 埃默里大学 | 2022-08-05 | — | — | CN | claimed |
| EP-3964554-A1 | COMPOSITON SENSITIVE TO UV-C RADIATION AND UV-C STERILIZATION OR DISINFECTION DOSIMETER | Terragene LLC (US) | 2022-03-09 | — | — | EP | claimed |
| EP-4743588-A2 | TREATMENT OF SAMPLES CONTAINING NUCLEIC ACIDS | BioSpyder Technologies, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12607931-B2 | Photosensitive transfer material, light shielding material, LED array, and electronic apparatus | FUJIFILM CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| EP-4714452-A1 | METHODS FOR TREATING SARS COV-2 INFECTIONS | Gilead Sciences, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-3958047-B1 | OPTICAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4701454-A1 | WRAPPER WITH PH INDICATOR FOR AEROSOL-GENERATING ARTICLE | Philip Morris Products S.A. (CH) | 2026-03-04 | — | — | EP | disclosed |
| US-12552745-B2 | Compound for optical materials, curable composition, cured body, and optical article | TOKUYAMA CORPORATION (JP) | 2026-02-17 | — | — | US | disclosed |
| US-20250355282-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-11-20 | — | — | US | disclosed |
| EP-4067998-B1 | EO/PO MODIFIED 9-PHENYLACRIDINE PHOTOSENSITIZERS FOR USE IN PHOTOSENSITIVE RESINS IN THE MANUFACTURE OF PRINTED CIRCUIT BOARDS | CHANGZHOU TRONLY NEW ELECTRONIC MAT CO LTD (CN) | 2025-11-12 | — | — | EP | disclosed |
| WO-2022045203-A1 | TRANSFER FILM, MANUFACTURING METHOD FOR LAMINATE, AND MANUFACTURING METHOD FOR CIRCUIT WIRING | 富士フイルム株式会社 | 2022-03-03 | — | — | WO | disclosed |
| CN-114096899-A | Polarizing film and method for producing same | 株式会社可乐丽 | 2022-02-25 | — | — | CN | disclosed |
| EP-3958044-A1 | OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, CURED PRODUCT, OPTICAL MATERIAL, PLASTIC LENS, METHOD FOR MANUFACTURING OPTICAL MATERIAL, AND METHOD FOR USING OPTICAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2022-02-23 | — | — | EP | disclosed |
| EP-3958047-A1 | OPTICAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2022-02-23 | — | — | EP | disclosed |
| EP-3951443-A1 | METHOD FOR PRODUCING OPTICAL MATERIAL, AND POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-114026199-A | Polarizing luminescent film, polarizing luminescent sheet, and display device containing water-soluble coumarin compound or salt thereof | 日本化药株式会社 | 2022-02-08 | — | — | CN | disclosed |
| CN-114008497-A | Polarizing film and method for producing same | 株式会社可乐丽 | 2022-02-01 | — | — | CN | disclosed |
| WO-2022019321-A1 | COMPOSITION, TRANSFER FILM, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING CIRCUIT WIRING, AND METHOD FOR PRODUCING ELECTRONIC DEVICE | 富士フイルム株式会社 | 2022-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12607931-B2 | Photosensitive transfer material, light shielding material, LED array, and electronic apparatus | SETD1B, NLRP1, MAP1LC3B | THRB 2370/4885ALDH1A1 1082/4885CYP3A4 3299/4885 |
| US-12552745-B2 | Compound for optical materials, curable composition, cured body, and optical article | C5, SCO2, ZYX | THRB 2158/4885ALDH1A1 1308/4885CYP3A4 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.